Interim results and dividend declaration AfroCentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 (“the Company") Summarised unaudited interim results for the six months ended 31 December 2020 and dividend declaration Introduction to the AfroCentric Group AfroCentric is a Level 1 black-owned JSE listed investment holding company, which owns and operates a diverse range of healthcare related enterprises, which include, specialised medical scheme administration and management, the supply of pharmaceuticals, including a range of healthcare products and services, to both the public and private healthcare sectors. A principal objective of the group, is to ensure the delivery of efficient health management services and the distribution of quality products, all at manageable and affordable cost, for the benefit of scheme clients, scheme members and the group’s growing customer base. AfroCentric has been able to successfully broaden its interests in the industry, by continuing to pursue new opportunities, to expand and rationalise its presence in the healthcare sector. The Board is pleased to present a summary of the Company’s results for the six months ended 31 December 2020. Salient Features % Unaudited six Unaudited six change months ended months ended 31 December 31 December 2020 2019 Total revenue 25.3 3 898.2 million 3 111.3 million Operating profit 16.5 511.8 million 439.3 million Operating profit (excluding lease reversals) 17.9 469.1 million 398.0 million Healthcare Services Operating profit 16.4 313.5 million 269.4 million Healthcare Retail Operating profit 20.9 155.6 million 128.7 million Profit before tax 19.1 320.1 million 268.7 million Profit after tax 13.0 226.5 million 200.5 million Basic earnings (rands) 8.3 146.0 million 134.8 million Headline earnings (rands) 10.9 149.5 million 134.7 million Basic earnings (cents per share) 8.3 25.43 23.48 Headline earnings (cents per share) 10.9 26.03 23.47 Weighted average number of ordinary shares 574.3 million 574.2 million Dividends The Board has pleasure in announcing that an interim gross dividend per ordinary share of 17 cents has been declared for the six months ended 31 December 2020. Dividends are subject to Dividends Withholding Tax. The payment date for the dividend is Monday, 17 May 2021. • Dividends have been declared out of profits available for distribution. • South African Dividends Withholding Tax rate is 20%. • The gross dividend amount is 17 cents per ordinary share. • The net cash dividend amount is therefore 13.60000 cents per ordinary share. • The Company has 574 951 251 ordinary shares in issue as at the declaration date. • The Company’s income tax reference number is 9600/148/71/3. The salient dates relating to the dividend are as follows: Last day to trade cum dividend Tuesday, 11 May 2021 Shares commence trading ex-dividend Wednesday, 12 May 2021 Dividend record date Friday, 14 May 2021 Dividend payment date Monday, 17 May 2021 Share certificates for ordinary shares may not be dematerialised or rematerialized between Wednesday, 12 May 2021 and Friday, 14 May 2021, both days inclusive. Full Announcement This short-form announcement is the responsibility of the Directors of the Company and is a summary of the information in the full announcement which is available for viewing on the following websites: Company’s website: http://www.afrocentric.za.com/inv-reporting.php. JSE website: https://senspdf.jse.co.za/documents/2021/jse/isse/act/act2021.pdf Any investment decision by investors and/or shareholders should be based on consideration of the full announcement, copies of which are also available for inspection at our offices on work-days during business hours, at no charge: On behalf of the Board Dr ATM Mokgokong Mr A Banderker Chairperson Group Chief Executive Officer Johannesburg 9 March 2021 Sponsor: Sasfin Capital (a member of Sasfin Group) Date: 09-03-2021 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.